Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gökhan Ucar"'
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Autor:
Serhat Sekmek, Gökhan Ucar, Irfan Karahan, Dogan Bayram, Selin Aktürk Esen, Ismet Seven, Mehmet Ali Nahit Sendur, Dogan Uncu
Publikováno v:
African Journal of Urology, Vol 29, Iss 1, Pp 1-7 (2023)
Abstract Background Bladder cancer surgery is critical for treatment, and systemic treatment before or after cystectomy may be necessary. We aimed to investigate the efficacy and response to neoadjuvant and adjuvant treatments. Methods Data on 93 pat
Externí odkaz:
https://doaj.org/article/21658d6657404a778e8cb88f1c4cbfc7
Autor:
Okan Aytekin, Simge Kirmizigul Kerinc, Abdurrahman Alp Tokalioglu, Yesim Ozkaya Ucar, Fatih Kilic, Gunsu Kimyon Comert, Gokhan Ucar, Burak Civelek, Taner Turan
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Background This study aimed to determine the effect of neoadjuvant chemotherapy (NACT) on the complex surgical procedures required in addition to staging surgery for the need to achieve a residual tumor 1 cm or less in a population of stage
Externí odkaz:
https://doaj.org/article/3d1e2e88f6c84d3792935af20799e832
Autor:
Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal cell carcinoma (mRCC). A total of 706patients with mRCC treated with tyrosine kin
Externí odkaz:
https://doaj.org/article/ff731989e9c14a97850334af8794a507
Autor:
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 5 (2022)
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be preferred.
Externí odkaz:
https://doaj.org/article/76c42bc31695447ca49b70652deb5b62
Autor:
Yakup Ergun, Oznur Bal, Mutlu Dogan, Gokhan Ucar, Merve Dirikoc, Yusuf Acikgoz, Ferhat Bacaksiz, Dogan Uncu
Publikováno v:
Journal of Research in Medical Sciences, Vol 25, Iss 1, Pp 14-14 (2020)
Background: Primary tumor resection (PTR) in metastatic colorectal cancer (mCRC) has not been suggested by guidelines, since new systemic chemotherapy options have improved overall survival. However, the effect of PTR is still controversial in mCRC.
Externí odkaz:
https://doaj.org/article/4efa496b20df4858b783627211a03092